Fda
3 articles

AI
AI in diagnostics market surges past $1.5 billion valuation
The global AI in diagnostics market, valued at USD 1.
Arjun Mehta·June 27, 2026

Industry Insights
What is algorithmic bias in AI systems and why does it matter?
As of May 13, 2024, the FDA had approved 882 AI-enabled Medical Devices, with 191 new entries, rapidly integrating algorithms into life-critical decisions, according to Biases in AI: Acknowledging and
Omar Haddad·June 7, 2026

Future Trends
AI accelerates oncology trials, FDA shapes AI-driven research
A novel AI-generated TNIK inhibitor recently completed a Phase 2a trial for idiopathic pulmonary fibrosis, demonstrating AI's shift from data analysis to active therapeutic compound design.
Arjun Mehta·May 15, 2026